Fig. 1From: Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in IndiaSummary of treatment-emergent adverse events (TEAEs) by prior dexamethasone intravitreal implant (DEX) treatment status. aThe severity of an AE (eyelid ptosis) was noted to be “mild” as clarified by a data clarification form. However, this information was not reported in the databaseBack to article page